Rankings
▼
Calendar
VRCA FY 2016 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
VRCA
Verrica Pharmaceuticals Inc.
$59M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.74
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$9,000
Balance Sheet
Total Assets
$544,000
Total Liabilities
$3M
Stockholders' Equity
-$3M
Cash & Equivalents
$527,000
← Q1 2017
All Quarters
